Showing results (1-10 of 740) with videos related to
Sort By:
Pageof 74
International Journal of Radiation Oncology, Biology, Physics|August 14, 2021
Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 TrialChristian Baues, Helen Goergen, Michael Fuchs, et al.Expert Review of Anticancer Therapy|September 15, 2010
The role of PET in Hodgkin's lymphoma and its impact on radiation oncologyCarsten Kobe, Markus Dietlein, Jan Kriz, et al.Expert Review of Hematology|November 19, 2010
Hodgkin's lymphoma: current treatment strategies and novel approachesDennis A Eichenauer, Michael Fuchs, Peter Borchmann, et al.Leukemia & Lymphoma|December 4, 2018
Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study GroupStefanie Kreissl, Helen Goergen, Horst Müller, et al.Critical Reviews in Oncology/Hematology|March 14, 2016
PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma-a systematic review and meta-analysisMarie T Sickinger, Bastian von Tresckow, Carsten Kobe, et al.The Cochrane Database of Systematic Reviews|January 10, 2015
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphomaMarie-Therese Sickinger, Bastian von Tresckow, Carsten Kobe, et al.Blood|September 1, 2018
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphomaCarsten Kobe, Helen Goergen, Christian Baues, et al.Hematology. American Society of Hematology. Education Program|January 18, 2011
The past: what we have learned in the last decadePeter Borchmann, Andreas EngertOnkologie|February 13, 2008
Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's LymphomaRoland Schnell, Markus Dietlein, Klaus Schomäcker, et al.British Journal of Haematology|January 24, 2021
Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study GroupDennis A Eichenauer, Horst Müller, Leonard Elger, et al.Pageof 74